Chandler A Sparks

Mr. Chandler A Sparks

Hackensack Meridian Health, Edison, New Jersey, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in JBJS Open Access
Verified
Journal Article
Open access
CSChandler A Sparks
Chandler A Sparks
SFSydney M. Fasulo
Sydney M. Fasulo
JWJordan T. Windsor
Jordan T. Windsor
VBVita Bankauskas
Vita Bankauskas
ECEdward V. Contrada
Edward V. Contrada
ASAnthony J. Scillia
Anthony J. Scillia
Background: ChatGPT is an artificial intelligence chatbot capable of providing human-like responses for virtually every possible inquiry. This advancement has provoked public interest regarding the use of ChatGPT, including in health care. The purpose of the present study was to investigate the quantity and accuracy of ChatGPT outputs for general patient-focused inquiries regarding 40 orthopaedic conditions. Methods: For each of the 40 conditions, ChatGPT (GPT-3.5) was prompted with the text “I have been diagnosed with [condition]. Can you tell me more about it?” The numbers of treatment options, risk factors, and symptoms given for each condition were compared with the number in the corresponding American Academy of Orthopaedic Surgeons (AAOS) OrthoInfo website article for information quantity assessment. For accuracy assessment, an attending orthopaedic surgeon ranked the outputs in the categories of <50%, 50% to 74%, 75% to 99%, and 100% accurate. An orthopaedics sports medicine fellow also independently ranked output accuracy. Results: Compared with the AAOS OrthoInfo website, ChatGPT provided significantly fewer treatment options (mean difference, −2.5; p < 0.001) and risk factors (mean difference, −1.1; p = 0.02) but did not differ in the number of symptoms given (mean difference, −0.5; p = 0.31). The surgical treatment options given by ChatGPT were often nondescript (n = 20 outputs), such as “surgery” as the only operative treatment option. Regarding accuracy, most conditions (26 of 40; 65%) were ranked as mostly (75% to 99%) accurate, with the others (14 of 40; 35%) ranked as moderately (50% to 74%) accurate, by an attending surgeon. Neither surgeon ranked any condition as mostly inaccurate (<50% accurate). Interobserver agreement between accuracy ratings was poor (κ = 0.03; p = 0.30). Conclusions: ChatGPT provides at least moderately accurate outputs for general inquiries of orthopaedic conditions but is lacking in the quantity of information it provides for risk factors and treatment options. Professional organizations, such as the AAOS, are the preferred source of musculoskeletal information when compared with ChatGPT. Clinical Relevance: ChatGPT is an emerging technology with potential roles and limitations in patient education that are still being explored.

18 June 2024 in Cureus
Verified
Journal Article
Open access
PDF file
CSChandler A Sparks
Chandler A Sparks
MKMatthew J. Kraeutler
Matthew J. Kraeutler
GCGrace A Chester
Grace A Chester
ECEdward V. Contrada
Edward V. Contrada
EZEric Zhu
Eric Zhu
ASAnthony J. Scillia
Anthony J. Scillia
Background: Chat Generative Pre-Trained Transformer (ChatGPT) is an artificial intelligence (AI) chatbot capable of delivering human-like responses to a seemingly infinite number of inquiries. For the technology to perform certain healthcare-related tasks or act as a study aid, the technology should have up-to-date knowledge and the ability to reason through medical information. The purpose of this study was to assess the orthopedic knowledge and reasoning ability of ChatGPT by querying it with orthopedic board-style questions. Methodology: We queried ChatGPT (GPT-3.5) with a total of 472 questions from the Orthobullets dataset (n = 239), the 2022 Orthopaedic In-Training Examination (OITE) (n = 124), and the 2021 OITE (n = 109). The importance, difficulty, and category were recorded for questions from the Orthobullets question bank. Responses were assessed for answer choice correctness if the explanation given matched that of the dataset, answer integrity, and reason for incorrectness. Results: ChatGPT correctly answered 55.9% (264/472) of questions and, of those answered correctly, gave an explanation that matched that of the dataset for 92.8% (245/264) of the questions. The chatbot used information internal to the question in all responses (100%) and used information external to the question (98.3%) as well as logical reasoning (96.4%) in most responses. There was no significant difference in the proportion of questions answered correctly between the datasets (P = 0.62). There was no significant difference in the proportion of questions answered correctly by question category (P = 0.67), importance (P = 0.95), or difficulty (P = 0.87) within the Orthobullets dataset questions. ChatGPT mostly got questions incorrect due to information error (i.e., failure to identify the information required to answer the question) (81.7% of incorrect responses). Conclusions: ChatGPT performs below a threshold likely to pass the American Board of Orthopedic Surgery (ABOS) Part I written exam. The chatbot’s performance on the 2022 and 2021 OITEs was between the average performance of an intern and to second-year resident. A major limitation of the current model is the failure to identify the information required to correctly answer the questions.

CBCynthia Blanton
Cynthia Blanton
Jared BarrottJared Barrott
Jared Barrott
KKKADEN KUNZ
KADEN KUNZ
EBElla Bunde
Ella Bunde
HSHailey M. Streff
Hailey M. Streff
AGAnnette M Gabaldon
Annette M Gabaldon
Optimizing peak bone mass is critical to healthy aging. Beyond the established roles of dietary minerals and protein on bone integrity, fatty acids and polyphenols modify bone structure. This study investigated the effect of a diet containing hempseeds (HS), which are rich in polyunsaturated fatty acids and polyphenols, on bone mineral density, bone cell populations and body composition. Groups (n = 8 each) of female C57BL/6 mice were fed one of three diets (15% HS by weight; 5% HS; 0% HS (control)) from age 5 to 30 weeks. In vivo whole-body composition and bone mineral density and content were measured every 4 weeks using dual-energy X-ray absorptiometry. Ex vivo humeri cell populations in the epiphyseal plate region were determined by sectioning the bone longitudinally, mounting the sections on slides and staining with tartrate-resistant acid phosphatase and alkaline phosphatase stain to identify osteoclasts and osteoblasts, respectively. Mixed models with repeated measures across experimental weeks showed that neither body weight nor body weight gain across weeks differed among groups yet mice fed the 15% HS diet consumed significantly more food and more kilocalories per g body weight gained than those fed the 5% HS and control diets (p < 0.0001). Across weeks, fat mass was significantly higher in the 5% HS versus the control group (p = 0.02). At the end point, whole-body bone mineral content was significantly higher in the control compared to the 5% HS group (p = 0.02). Humeri from both HS groups displayed significantly lower osteoblast densities compared to the control group (p < 0.0001). No relationship was seen between osteoblast density and body composition measurements. These data invite closer examination of bone cell activity and microarchitecture to determine the effect of habitual HS consumption on bone integrity.

11 October 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
CSChandler A Sparks
Chandler A Sparks
HSHailey M. Streff
Hailey M. Streff
DWDerrick W. Williams
Derrick W. Williams
CBCynthia Blanton
Cynthia Blanton
AGAnnette M Gabaldon
Annette M Gabaldon
Numerous seed and seed extract diets have been investigated as a means of combating age-related bone loss, with many findings suggesting that the seeds/extracts confer positive effects on bone. Recently, there has been rising interest in the use of dietary hempseed in human and animal diets due to a perceived health benefit from the seed. Despite this, there has been a lack of research investigating the physiologic effects of dietary hempseed on bone. Previous studies have suggested that hempseed may enhance bone strength. However, a complete understanding of the effects of hempseed on bone mineralization, bone micro-architecture, and bone biomechanical properties is lacking. Using a young and developing female C57BL/6 mouse model, we aimed to fill these gaps in knowledge. From five to twenty-nine weeks of age, the mice were raised on either a control (0%), 50 g/kg (5%), or 150 g/kg (15%) hempseed diet (n = 8 per group). It was found that the diet did not influence the bone mineral density or micro-architecture of either the right femur or L5 vertebrae. Furthermore, it did not influence the stiffness, yield load, post-yield displacement, or work-to-fracture of the right femur. Interestingly, it reduced the maximum load of the right femur in the 15% hempseed group compared to the control group. This finding suggests that a hempseed-enriched diet provides no benefit to bone in young, developing C57BL/6 mice and may even reduce bone strength.

1 December 2023 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
CSChandler A Sparks
Chandler A Sparks
RARyeim B. Ansaf
Ryeim B. Ansaf
AGAnnette M. Gabaldón
Annette M. Gabaldón
There is increasing awareness that cortical and cancellous bone differ in regulating and responding to pharmaceutical therapies, hormone therapies, and other treatments for age-related bone loss. Three-point bending is a common method used to assess the influence of a treatment on the mid-diaphysis region of long bones, which is rich in cortical bone. Uniaxial compression testing of mouse vertebrae, though capable of assessing bones rich in cancellous bone, is less commonly performed due to technical challenges. Even less commonly performed is the pairing of three-point bending and compression testing to determine how a treatment may influence a long bone's mid-diaphysis region and a vertebral centrum similarly or differently. Here, we describe two procedures to make compression testing of mouse lumbar vertebrae a less challenging method to perform in parallel with three-point bending: first, a procedure to convert a three-point bending machine into a compression testing machine, and second, an embedding method for preparing a mouse lumbar vertebra loading surface.

21 September 2026 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
CSChandler A Sparks
Chandler A Sparks
SASamuel P. Alfonsi
Samuel P. Alfonsi
TMTy L. Monty
Ty L. Monty
BKBenjamin Kerzner
Benjamin Kerzner
GGGuillaume Girardot
Guillaume Girardot
JWJoel C. Williams
Joel C. Williams
Background: Patient-reported outcome measures (PROMs) quantify symptoms and function, but the degree to which a patient considers an improvement or outcome after surgery to be meaningful can be difficult to quantify. Benchmarking improvement using metrics like the minimum clinically important difference (MCID), patient acceptable symptom state (PASS), and substantial clinical benefit (SCB) can help clinicians know what outcome or how large of an improvement is large enough to matter clinically and to their patients. Yet, procedure-specific thresholds for Bernese periacetabular osteotomy (PAO) remain poorly defined, and factors associated with clinically meaningful outcome achievement have yet to be identified. Questions/purposes: For patients who underwent PAO, we sought to: (1) determine the MCID, PASS, and SCB absolute thresholds for the Hip Disability and Osteoarthritis Outcome Score (HOOS) and the 12-Item International Hip Outcome Tool (iHOT-12); (2) determine the proportion of patients achieving the MCID, PASS, and SCB across individual PROMs as well as for any PROM (that is, ≥ 1 PROM); and (3) identify patient factors that are independently associated with clinically meaningful outcome achievement. Methods: Patients who underwent a Bernese PAO between June 2020 and December 2024 performed by a single surgeon were identified through a longitudinally maintained institutional hip preservation repository. During the study period, 162 patients had a PAO. A total of 7% of those (12 of 162) were excluded because they underwent unplanned reoperation; of the 150 who remained, 11% (17 of 150) were lost to follow-up before 1 year, leaving 82% (133 of 162) for final analysis with ≥ 1 postoperative PROM at a minimum of 1-year follow-up. The included patient population had a mean ± SD age of 24 ± 8 years, 94% (125 of 133) were women, most reported being physically active (51% [68 of 133]), and most underwent the PAO with a concomitant procedure, with staged hip arthroscopy being the most common (67% [89 of 133]). The MCID thresholds were established using the distribution method, whereas PASS and SCB absolute thresholds were calculated using the anchor question–based method. The proportion of patients achieving the MCID, PASS, and SCB for individual PROMs as well as for any PROM (that is, ≥ 1 PROM) was recorded. Stepwise multivariate logistic regression was used to identify factors independently associated with achieving the MCID, PASS, and SCB for any PROM. To determine the MCID, PASS, and SCB absolute thresholds for the HOOS and iHOT-12, thresholds were calculated as follows, respectively: HOOS symptoms (12, 62, 78), HOOS pain (12, 79, 80), HOOS activities of daily living (12, 83, 92), HOOS sports and recreation (16, 57, 72), HOOS quality of life (14, 61, 65), and iHOT-12 (16, 75, 77). Results: When evaluating the proportion of patients achieving these thresholds across individual and combined metrics, we found that the MCID was achieved by 61% (62 of 102) to 73% (74 of 102) of patients for individual PROMs, with 83% (101 of 122) achieving it for at least one measure. The proportion of PASS achievement ranged from 52% (65 of 125) to 73% (85 of 117) across PROMs, with 77% (103 of 133) overall. The SCB achievement proportion was 47% (55 of 117) to 55% (64 of 117) per PROM and 70% (93 of 133) overall. With respect to identifying independent patient factors associated with clinically meaningful outcome achievement, a preoperative pathologic gait was independently associated with MCID achievement (OR 5 [95% confidence interval (CI) 1.3 to 33.6]; p = 0.046). Preoperative symptom duration > 2 years (OR 0.3 [95% CI 0.1 to 0.9]; p = 0.048) and femoral antetorsion > 25° (OR 0.2 [95% CI 0.1 to 0.9]; p = 0.03) were associated with lower odds of PASS achievement. Preoperative symptom duration > 2 years also was associated with lower odds of SCB achievement in a negative fashion (OR 0.4 [95% CI 0.2 to 0.9]; p = 0.04). Conclusion: The present study defined MCID, PASS, and SCB thresholds for the HOOS and iHOT-12 after Bernese PAO, demonstrating that while the majority of patients achieve these benchmarks, a notable subset fall short of a satisfactory outcome. We identified specific patient factors, including preoperative symptom duration > 2 years and femoral antetorsion > 25°, that negatively impact clinically meaningful outcome achievement. These findings highlight chronicity and complex structural anatomy as markers of more advanced condition that may limit the efficacy of Bernese PAO. Surgeons should be cognizant of these factors and utilize them during preoperative counseling. Ultimately, these procedure-specific thresholds offer a more practical approach than raw outcome scores alone to improve risk stratification and track clinical success. Future studies are needed to validate these thresholds across larger, diverse populations, evaluate additional PROMs, establish anchor question–based thresholds for MCID, and determine the long-term durability of achieving these clinically meaningful outcomes. Level of Evidence: Level III, therapeutic study.